Press Releases
Search
-
08 Oct 2020
AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics
bioMérieux and the Africa Medical Supplies Platform (AMSP), have announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfol...
-
02 Sep 2020
First-Half 2020 Results
Organic sales growth of 15.7% in first-half 2020: €1,476 million in sales Up 15.8% as reported As expected, a mixed sales performance, with faster momentum in molecular biology solutions contrasting w...
-
16 Jul 2020
Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biothe...
-
09 Jul 2020
Second-Quarter 2020 Business Performance Preannouncement
In light of the withdrawal of its annual objectives, bioMérieux, a world leader in the field of in vitro diagnostics, today announced preliminary quarterly information about its business activity endi...
-
29 Jun 2020
bioMérieux issues a €200 million Euro PP bond
Marcy l’Étoile (France) - June 29, 2020 – bioMérieux, a global leader in the field of in vitro diagnostics, announces that it has successfully issued today a €200 million Euro PP new debt with a top-t...
-
15 Jun 2020
BIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the BIOFIRE® Respiratory Panel 2.1 plus (RP2.1plus) is CE marked. The BIOFIRE® Respiratory Panel 2.1 plus (RP2.1pl...